Ticker
ENTACompany Name
ENANTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 44.81M | 1.01 | $ 44.55M |
3/31/2025 | $ 60.21M | 1.31 | $ 45.95M |
12/31/2024 | $ 84.96M | 1.73 | $ 49.05M |
9/30/2024 | $ 37.84M | 0.66 | $ 57.53M |
6/30/2024 | $ 36.38M | 0.62 | $ 58.23M |
3/31/2024 | $ 67.51M | 1.24 | $ 54.61M |
12/31/2023 | $ 43.9M | 0.7 | $ 62.41M |
9/30/2023 | $ 89.36M | 1.42 | $ 62.79M |
6/30/2023 | $ 99.14M | 1.45 | $ 68.19M |
3/31/2023 | $ 77.15M | 2.4 | $ 32.17M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for ENANTA PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 87.74M ] / LiabilitesC [ $ 24.16M ]
(=) Cash Ratio [ 3.63 ]
Minimum
Jun 30, 2021
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |